To obtain documents, log on:
:
Not registered? Register me now
 

Public Higher Education Bulletin

 
University of Illinois at Chicago
Exemption #JMG773
Announcement of an Exempt Purchase
Award Info Published Monday August 12, 2019
Awarded to:
Vendor: GE Healthcare Bio-Sciences, Corp., Marlborough, MA
Amount: $387,745.38
Terms:  One-time transaction
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, August 12, 2019
The University awarded a contract for the Biacore 8K.
A new instrument, the Biacore 8K has 16 flow cells, allowing the researcher to immobilize eight different ligands on a single sensor chip. The Biacore 8K runs much faster than other SPR instruments with reduced sample injection time. The instrument will be used by researchers in the drug discovery process.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for performing sponsored research and other sponsored activities under grants and contracts funded by the sponsor or by sources other than State appropriations. (30 ILCS 500 / 1-13(b)(8)) The current Biacore T200 instrument is being used almost 100% of the time and users have to wait 4-5 weeks in order to schedule the next available instrument time. It is partly because Biacore T200 uses sensor chips that have only four flow cells, letting only two to three ligands to immobilize on a chip. The Biacore 8K has 16 flow cells, allowing researchers to immobilize eight different ligands on a single sensor chip. The Biacore 8K runs much faster than Biacore T200 with reduced sample injection time. These new features of Biacore 8K can reduce run time significantly, and therefore it can solve our long waiting time for users since each experiment will take much shorter time to run. In addition, the signal sensitivity also has improved a lot, benefitting the improved detection of very small fragment compounds. Fragment compound screening became a key step for drug discovery process, and hence Biacore 8K will benefit many PIs who are interested in drug discovery.

For additional information, contact:
Jeffrey Walsh
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 355-3568
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Bulletin Navigation

 
To obtain documents, log on:
Exemption Document
  • JMG773GEHealthcare.pdf (144 KB)